Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer [Phase 2]
A Phase 2 neoadjuvant trial evaluating ixabepilone with carboplatin and trastuzumab in HER2-positive locally advanced breast cancer has comp…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer [Phase 1, Phase 2]
Phase I/II clinical trial evaluating the combination of sorafenib and ixabepilone in HER2-negative metastatic breast cancer has completed wi…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases [Phase 2]
Phase 2 trial update of Yttrium-90 glass microsphere radioembolization (TheraSphere) for patients with liver metastases, completed with resu…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Participation Restrictions in Breast Cancer Survivors [NA]
This is an update on a completed clinical trial. It describes participation restrictions for breast cancer survivors.
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BC [Phase 2]
Phase 2 neoadjuvant trial evaluating FEC chemotherapy with G-CSF support followed by ixabepilone with G-CSF support in breast cancer; the st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy. [Phase 2]
Phase 2 study evaluating trastuzumab in combination with capecitabine in patients with HER2-positive metastatic or recurrent breast cancer a…
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer. [Phase 2]
Phase 2 trial update evaluating the combination of lapatinib and capecitabine in patients aged 70 and older with HER2-positive metastatic br…
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer [Phase 3]
A Phase 3 trial comparing high-dose chemotherapy with peripheral stem cell transplantation to standard therapy in women with locally recurre…
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty
An update on a completed clinical trial evaluating cognitive difficulties (chemo brain) and quality of life in women with breast cancer unde…
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer [Phase 3]
A Phase 3 trial evaluating combination chemotherapy versus observation after surgery in women with relapsed nonmetastatic breast cancer has …
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating panitumumab with gemcitabine and carboplatin in metastatic triple-negative breast cancer; the study has been comple…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating Abraxane plus carboplatin as first-line therapy for triple-negative metastatic breast cancer was terminated; result…
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)
This clinical trial update reports results from a Phase I study of computed optical margin assessment in breast cancer surgery. The results …
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography [EARLY_Phase 1]
Early-phase (Phase 1) clinical trial evaluating the copper-64 radiotracer 64Cu-DOTA-AE105 for diagnosing aggressive cancers with PET; the st…
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Gentamicin Versus Clindamycin Versus Normal Saline Lavage in Axilla [Phase 3]
A Phase 3 randomized trial comparing gentamicin lavage to clindamycin lavage and normal saline lavage in the axilla for breast cancer has co…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer [Phase 2]
A Phase 2 trial evaluating the feasibility and optimal sequencing of postoperative adjuvant FEC (fluorouracil, epirubicin, cyclophosphamide)…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Caelyx Adjuvant in Elderly Breast Cancer [Phase 2]
This is a Phase 2 clinical trial update evaluating Caelyx (pegylated liposomal doxorubicin) as adjuvant therapy in elderly patients with bre…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1 [Phase 1]
Phase 1 clinical trial update evaluating tumor cellular proliferation using the PET radiotracer [18F]ISO-1 in patients with breast cancer, h…
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Early Breast Cancer [Phase 3]
A Phase 3 trial comparing intra-operative radiotherapy with post-operative radiotherapy for women with early breast cancer has completed, wi…
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Proton Therapy for Lymph Nodes in Breast Cancer [NA]
This clinical trial update notes the completion of a study evaluating proton therapy to target lymph nodes in breast cancer and that results…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer [Phase 1]
Phase 1 trial results for MM-111 in combination with Herceptin in patients with advanced HER2-amplified, heregulin-positive breast cancer we…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors [Phase 2]
A Phase II trial evaluating trastuzumab plus paclitaxel for HER2-positive locally advanced breast cancer and epirubicin plus docetaxel for H…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen [Phase 2]
A Phase 2 study evaluated the combination of lapatinib and tamoxifen in patients with locally advanced or metastatic breast cancer that prog…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Menopause and Meditation for Breast Cancer Survivors [Phase 1, Phase 2]
A clinical trial update indicates completion of Phase 1 and Phase 2 studies evaluating menopause and meditation for breast cancer survivors.
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women [Phase 2]
Phase 2 clinical trial assessing whether a telephone-based prevention care manager increases cancer screening rates among minority and low-i…